{
    "nctId": "NCT04149522",
    "briefTitle": "Evaluation of Mepitel Film\u00ae in Preventing Epidermitis in Patients Receiving Radiation Therapy for Breast Cancer",
    "officialTitle": "Mepitel Film\u00ae Prophylaxis For Breast Cancer Patients Receiving Breast Radiotherapy At High Risk For Moist Desquamation: A Phase II Study",
    "overallStatus": "TERMINATED",
    "conditions": "Breast Cancer, Radiotherapy; Adverse Effect, Dermatitis or Eczema, Radiotherapy Side Effect, Radiation Burn, Radiation Dermatitis, Radiotherapy; Complications",
    "studyType": "INTERVENTIONAL",
    "phase": "PHASE2",
    "allocation": "NON_RANDOMIZED",
    "primaryPurpose": "PREVENTION",
    "enrollmentCount": 40,
    "primaryOutcomeMeasure": "Evaluate the efficacy of use of Mepitel Film\u00ae in the prevention of grade II or higher radiation epidermitis in high-risk patients undergoing radiotherapy for breast cancer",
    "eligibilityCriteria": "Inclusion Criteria:\n\n1. Women 18 - 80 years of age\n2. Biopsy-proven diagnosis of breast cancer (Stage 0 - II) with the breast tumor completely removed\n3. Whole breast or chest wall irradiation with or without ipsilateral axillary radiotherapy\n4. Women of child-bearing potential must use an effective form of birth control\n\nExclusion Criteria:\n\n1. Women who are pregnant or lactating\n2. Women with evident skin irritation or skin infection (i.e. active rash, pre-existing dermatitis) or known allergy to adhesives or tapes; or known allergy to the Mepitel Film\u00ae\n3. Women with a chest abnormality that would preclude application of the Film;\n4. Women who in the investigator's opinion are not capable of completing the trial or following trial procedures",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}